Published in Biochem Soc Trans on November 01, 1995
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
Structure, evolution, and biology of the MUC4 mucin. FASEB J (2007) 1.75
Lactobacillus adhesion to mucus. Nutrients (2011) 1.22
Current status of mucins in the diagnosis and therapy of cancer. Biofactors (2009) 1.17
Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer (2006) 0.97
Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconj J (1999) 0.94
Human colonocyte detoxification. Gut (1997) 0.84
The interaction of large bowel microflora with the colonic mucus barrier. Int J Inflam (2010) 0.82
Mucin pattern reflects the origin of the adenocarcinoma in Barrett's esophagus: a retrospective clinical and laboratorial study. World J Surg Oncol (2009) 0.81
Mucin glycoarray in gastric and gallbladder epithelia. J Carcinog (2007) 0.75
Deacetylation of sialic acid by esterases potentiates pneumococcal neuraminidase activity for mucin utilization, colonization and virulence. PLoS Pathog (2017) 0.75
Nucleotide variability and linkage disequilibrium patterns in the porcine MUC4 gene. BMC Genet (2012) 0.75
p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res (1990) 5.70
General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial. Lancet (2008) 4.18
Chemistry, metabolism, and biological functions of sialic acids. Adv Carbohydr Chem Biochem (1982) 3.53
The APC gene product in normal and tumor cells. Proc Natl Acad Sci U S A (1993) 3.25
Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res (1997) 2.33
Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene (2008) 2.26
The immune response to thetaX 174 in man. I. Primary and secondary antibody production in normal adults. Clin Exp Immunol (1973) 2.10
VEGF 165 b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. Br J Cancer (2008) 2.09
Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr Biol (1994) 2.05
The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients. Int J Cancer (1984) 2.04
Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene (1999) 2.00
Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut (2000) 1.99
Mucins in the gastrointestinal tract in health and disease. Front Biosci (2001) 1.99
Butyrate acts as a survival factor for colonic epithelial cells: further fuel for the in vivo versus in vitro debate. Gastroenterology (1997) 1.99
Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int J Cancer (1993) 1.94
Structure, function and metabolism of sialic acids. Cell Mol Life Sci (1998) 1.85
Conserved sequences in bacterial and viral sialidases. Glycoconj J (1989) 1.84
Mucin glycoproteins in neoplasia. Glycoconj J (1996) 1.81
Sialic acids in molecular and cellular interactions. Int Rev Cytol (1997) 1.79
The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76
An acidic environment leads to p53 dependent induction of apoptosis in human adenoma and carcinoma cell lines: implications for clonal selection during colorectal carcinogenesis. Oncogene (1999) 1.64
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol (1992) 1.62
Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res (1990) 1.57
Characterization of sialic acids. Methods Enzymol (1978) 1.55
N-Glycolylneuraminic acid in human tumours. Biochimie (2001) 1.55
Apoptosis in colorectal tumour cells: induction by the short chain fatty acids butyrate, propionate and acetate and by the bile salt deoxycholate. Int J Cancer (1995) 1.54
Methylated bases in the host-modified deoxyribonucleic acid of Escherichia coli and bacteriophage lambda. J Bacteriol (1966) 1.53
PKC-delta is an apoptotic lamin kinase. Oncogene (2000) 1.53
Purification and properties of cloned Salmonella typhimurium LT2 sialidase with virus-typical kinetic preference for sialyl alpha 2----3 linkages. J Biochem (1991) 1.50
Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res (2000) 1.44
The sialidase superfamily and its spread by horizontal gene transfer. Mol Microbiol (1993) 1.40
Transmissible gastroenteritis coronavirus, but not the related porcine respiratory coronavirus, has a sialic acid (N-glycolylneuraminic acid) binding activity. J Virol (1996) 1.40
Colorectal cancer and dietary calcium intervention: a word of caution. Eur J Cancer Prev (1992) 1.39
Cloning and sequencing of a Clostridium perfringens sialidase gene. FEBS Lett (1988) 1.39
Agent Orange: exposure and policy. Am J Public Health (1991) 1.37
The circularity of the phage P22 linkage map. Genetics (1968) 1.37
A study of ras gene mutations in colonic adenomas from familial polyposis coli patients. Oncogene (1988) 1.35
Nonmyeloablative immunosuppressive regimen prolongs In vivo persistence of gene-modified autologous T cells in a nonhuman primate model. J Virol (2001) 1.34
BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene (1994) 1.34
Second locus of bacteriophage P22 necessary for the maintenance of lysogeny. J Virol (1968) 1.32
Modifications of cell surface sialic acids modulate cell adhesion mediated by sialoadhesin and CD22. Glycoconj J (1994) 1.30
The specificity of viral and bacterial sialidases for alpha(2-3)- and alpha(2-6)-linked sialic acids in glycoproteins. Biochim Biophys Acta (1983) 1.29
Functional groups of sialic acids involved in binding to siglecs (sialoadhesins) deduced from interactions with synthetic analogues. Eur J Biochem (1998) 1.29
Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. J Biol Chem (1991) 1.28
A study to determine the reasons for differences in the tumorigenicity of rat cell lines transformed by adenovirus 2 and adenovirus 12. Cold Spring Harb Symp Quant Biol (1980) 1.27
The catalytic activity of the Src family kinases is required to disrupt cadherin-dependent cell-cell contacts. Mol Biol Cell (2000) 1.26
A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer. Oncogene (1997) 1.23
Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N-acetylneuraminic acid. J Biol Chem (1980) 1.23
A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease. Health Technol Assess (2007) 1.22
Siglecs: a family of sialic-acid binding lectins. Glycobiology (1998) 1.22
[Action specificity of neuraminidase. The action of bacterial neuraminidase on isomeric N,O-diacetylneuraminic acid glycosides in the submaxilllary mucin of horse and cow]. Hoppe Seylers Z Physiol Chem (1968) 1.21
[Surgical techniques in hepatic resections: Ultrasonic aspirator versus Jet-Cutter. A prospective randomized clinical trial]. Zentralbl Chir (2001) 1.20
Binding of Plasmodium falciparum 175-kilodalton erythrocyte binding antigen and invasion of murine erythrocytes requires N-acetylneuraminic acid but not its O-acetylated form. Mol Biochem Parasitol (1992) 1.20
Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ (2006) 1.19
Apoptosis or necrosis for tumor immunotherapy: what's in a name? J Mol Med (Berl) (1999) 1.19
Effects of Pringle manoeuvre and ischaemic preconditioning on haemodynamic stability in patients undergoing elective hepatectomy: a randomized trial. Br J Anaesth (2004) 1.18
Introducing aptitude testing into medicine. BMJ (1989) 1.17
Migration of O-acetyl groups in N,O-acetylneuraminic acids. Eur J Biochem (1987) 1.15
Tumorigenicity and in vitro characteristics of rat liver epithelial cells and their adenovirus-transformed derivatives. Int J Cancer (1980) 1.15
The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. J Biol Chem (2000) 1.15
The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis--preliminary findings. Electrophoresis (1999) 1.15
Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem (1998) 1.14
Infections with Pseudomonas aeruginosa in patients with cystic fibrosis. Behring Inst Mitt (1997) 1.14
The biosynthesis of N-glycoloylneuraminic acid occurs by hydroxylation of the CMP-glycoside of N-acetylneuraminic acid. Biol Chem Hoppe Seyler (1988) 1.14
Optimal education techniques for basic surgical trainees: lessons from education theory. J R Coll Surg Edinb (1999) 1.13
Cloning, sequencing and expression of a sialidase gene from Clostridium sordellii G12. J Gen Microbiol (1989) 1.12
The sialidase gene from Clostridium septicum: cloning, sequencing, expression in Escherichia coli and identification of conserved sequences in sialidases and other proteins. Mol Gen Genet (1991) 1.12
Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells. Cancer Res (2000) 1.12
Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconj J (1996) 1.11
Coordinated modulation of the fibroblast growth factor dual receptor mechanism during transformation from human colon adenoma to carcinoma. Int J Cancer (1999) 1.10
Localization of the putative sialic acid-binding site on the immunoglobulin superfamily cell-surface molecule CD22. J Biol Chem (1996) 1.10
CMP-N-acetylneuraminic acid hydroxylase: the first cytosolic Rieske iron-sulphur protein to be described in Eukarya. FEBS Lett (1996) 1.10
O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Biochem (1994) 1.09
Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398. Int J Cancer (2000) 1.08
The release of N-acetyl- and N-glycolloyl-neuraminic acid from soluble complex carbohydrates and erythrocytes by bacterial, viral and mammalian sialidases. Biochem J (1981) 1.08
Butyrate can act as a stimulator of growth or inducer of apoptosis in human colonic epithelial cell lines depending on the presence of alternative energy sources. Carcinogenesis (1997) 1.07
Sialic acid--a determinant of the life-time of rabbit erythrocytes. Hoppe Seylers Z Physiol Chem (1974) 1.07
Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut (2000) 1.06
High-performance liquid chromatography assays for N-acetylglucosaminyltransferases involved in N- and O-glycan synthesis. Methods Enzymol (1989) 1.06
Immunodetection of cathepsins B and L present in and secreted from human pre-malignant and malignant colorectal tumour cell lines. Int J Cancer (1989) 1.06
Functional anatomy of human lacrimal duct epithelium. Anat Embryol (Berl) (1998) 1.05
Protein-sugar interactions. Purification by affinity chromatography of limulin, an N-acyl-neuraminidyl-binding protein. FEBS Lett (1975) 1.05
Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines. Glycobiology (1995) 1.05
Further structural and functional analogies between the repressor regions of phages P22 and lambda. Mol Gen Genet (1975) 1.04
Influence of preformed alpha-helix and alpha-helix induction on the activity of cationic antimicrobial peptides. J Pept Res (1998) 1.04
Antibodies to ADP-ATP carrier--an autoantigen in myocarditis and dilated cardiomyopathy--impair cardiac function. Circulation (1990) 1.02
TGF-beta expression in the human colon: differential immunostaining along crypt epithelium. Br J Cancer (1993) 1.02
The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc (1996) 1.02
Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming. Gene Ther (2006) 1.02
Neuraminic acid-specific modification and tritium labelling of gangliosides. Biochim Biophys Acta (1976) 1.02
Purification and characterization of neuraminidase from Clostridium perfringens. Hoppe Seylers Z Physiol Chem (1975) 1.02
Chemistry and biology of the acylneuraminic acids. Angew Chem Int Ed Engl (1973) 1.02
Control of glycoprotein synthesis: substrate specificity of rat liver UDP-GlcNAc:Man alpha 3R beta 2-N-acetylglucosaminyltransferase I using synthetic substrate analogues. Glycoconj J (1992) 1.02
The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomized, double-blind, placebo-controlled multicenter trial. Ann Surg (1997) 1.02
Occurrence of sialic acids in Drosophila melanogaster. Science (1992) 1.01